The British Neurotoxin Network (BNN) was founded in 2011 to gather British clinicians who use Botulinum toxin (BoNT-A) injections for the treatment of focal dystonia, spasticity, and other neurological disorders. It maintains information on clinics presenting both patients and doctors with the most appropriate medical centre for the treatment of each condition type.

For many years, we have been invited to represent the patient voice at their annual meeting. We welcome this valuable opportunity to ensure your voice is heard.